Answer
Delayed neurological effects, persistent immune or blood abnormalities and secondary cancers can occur, so extended safety monitoring is required.
Sources for this answer
- CARVYKTI 3.2 × 10^6 – 1 × 10^8 cells dispersion for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.